Filing Details
- Accession Number:
- 0000885590-11-000018
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2011-04-11 16:23:58
- Reporting Period:
- 2010-11-10
- Filing Date:
- 2011-04-11
- Accepted Time:
- 2011-04-11 16:23:58
- Original Submission Date:
- 2010-11-12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1343811 | Ann Norma Provencio | C/O 7150 Mississauga Road Mississauga A6 L5N 8M5 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2010-11-10 | 1,000 | $24.75 | 144,009 | No | 4 | P | Direct | |
Common Stock, No Par Value | Acquisiton | 2010-11-10 | 4,000 | $24.75 | 148,009 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Common Stock held in reporting person's IRA.
- 98,930 of these represent restricted share units that were previously reported in Table I.
- This amendment is being filed to correct the number of restricted share units/common shares that were reported in the original filing.
- Common Stock held in reporting person's 401K account.